Logo image of TNFA

TNF PHARMACEUTICALS INC (TNFA) Stock Analyst Earnings Estimates

NASDAQ:TNFA - Nasdaq - US62856X2018 - Common Stock - Currency: USD

0.479  -0.01 (-2.62%)

After market: 0.4999 +0.02 (+4.36%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2016 2017 2018 2019 2020 2021 2022
Revenue
YoY % growth
TNFA revenue by date.TNFA revenue by date.
2.96M
39.62%
3.35M
13.18%
1.67M
-50.15%
N/A
-100.00%
N/AN/AN/A
EBITDA
YoY % growth
TNFA ebitda by date.TNFA ebitda by date.
-3.04M
65.88%
-6.36M
-109.21%
-8.32M
-30.82%
N/A
60.10%
N/A
-269.28%
N/A
-134.91%
N/A
EBIT
YoY % growth
TNFA ebit by date.TNFA ebit by date.
-3.33M
63.84%
-6.61M
-98.50%
-8.55M
-29.35%
N/A
60.35%
N/A
-262.54%
N/A
-134.34%
N/A
46.94%
Operating Margin
TNFA operating margin by date.TNFA operating margin by date.
-112.50%-197.31%-511.98%N/AN/AN/AN/A
EPS
YoY % growth
TNFA eps by date.TNFA eps by date.
N/A
100.00%
-5,644.80N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
TNFA Yearly EPS VS EstimatesTNFA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 -5K -10K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2020
Q2Q % growth

100.00%
%
Q1 2020
Q2Q % growth

-100.00%
%
TNFA Yearly Revenue VS EstimatesTNFA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M 5M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A